ArticleDiscover oncology2025
Mendelian randomization analysis of immune cell traits and oral microbiota in nasopharyngeal carcinoma during radiotherapy.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the relationship between oral microbiota and the degree of oral mucosal injury during radiotherapy for nasopharyngeal carcinoma (NPC).
methodsFrom Jun 2022 to Apr 2023, 40 NPC patients (research group) with oral mucosal injury who received radiotherapy and their healthy family members 40 cases (control group) in department of head and neck radiotherapy, Meizhou People's Hospital were selected as the research population, to compare the diversity of oral mucosal flora alpha between the two groups. Subsequently, research group were graded as either mild (RTOG 1-II) or severe oral mucosal injury (RTOG III-IV) according to the RTOG classification. Samples of oral pharyngeal swab samples of patients were obtained for operational taxonomic units (OTUs) clustering, and the abundance table was obtained. Additionally, Mendelian randomization analysis examined genetic associations between immune cell traits and head and neck squamous cell carcinoma (HNSCC) risk using publicly available GWAS data.
resultsCompared to the control group, NPC patients showed significantly lower α-diversity of oral microbiota (lower Chao1, PD, and Faith's PD indices; p < 0.05). Patients with severe oral mucosal injury demonstrated reduced microbial diversity compared to those with mild injury. The relative abundance of Actinobacteria, Firmicutes, and Fusobacteria was higher in patients with severe injury, while Bacteroidetes, Patescibacteria, and Spirochaetes were lower. Mendelian randomization analysis identified specific immune cell traits associated with HNSCC risk, including potential protective effects of CD28 + CD8 + T cells and potential risk associations with CD24 + CD27 + B cells.
conclusionThere is a close relationship between oral mucosal injury during radiotherapy of NPC patients and oral microflora imbalance. In the future, we can prevent the occurrence of oral mucosal injury by regulating oral microbiota, so as to provide a more reliable guarantee of good prognosis for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.